Vascular endothelial growth factor and oxidative damage in cancer.
OBJECTIVE
VEGF may be an indicator for the angiogenic potential of a tumor and stimulates NO which plays complex roles in cancer. In our study, we investigated the levels of MDA, NO and VEGF in the plasma of various types cancer patients (untreated, yet).


METHODS
The level of VEGF was determined by using ELISA. Plasma MDA, NO and VEGF levels were measured in 45 patients with various cancer types and in 21 healthy subjects.


RESULTS
Plasma MDA and VEGF levels were significantly higher than those of the healthy subjects (p < 0,0001). NO levels of the patients were significantly lower vs. the healthy subjects (p < 0,001).


CONCLUSIONS
Increased plasma VEGF and MDA concentrations and decreased plasma NO levels have been found in patients with various types of human cancer. Howewer, the prognostic and clinical significance of plasma VEGF in cancer patients is unknown.
Ilhan
Nevin
N
Department of Biochemistry and Clinical Biochemistry, Firat University, Medical College, Elazig, Turkey. drnilhan@yahoo.com
Ilhan
Necip
N
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D008315:Malondialdehyde / Q000097:blood / Q000378:metabolism*; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood / Q000503:physiopathology*; D009389:Neovascularization, Pathologic; D009569:Nitric Oxide / Q000097:blood / Q000378:metabolism; D018384:Oxidative Stress; D042461:Vascular Endothelial Growth Factor A / Q000097:blood / Q000378:metabolism*
D042461:Vascular Endothelial Growth Factor A; D009569:Nitric Oxide; D008315:Malondialdehyde